Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Psychedelics Funding Coming Down

Bar chart: Venture funding in psychedelics, 2019-2023

Technology intelligence company CB Insights says this week that psychedelic therapies and services are generating little interest among venture investors this year, with only nine deals totaling $21 million. . . . → Read More: Infographic – Psychedelics Funding Coming Down

Crispr Therapy Shown to Remove E. Coli in Gut

New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut

Trial Underway Testing Psychedelic Drug for Depression

Sonoran desert toad

The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression. . . . → Read More: Trial Underway Testing Psychedelic Drug for Depression

Biotech to Design Disease-Blocking Drugs, Gains $75M

Chemical atom model

A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round. . . . → Read More: Biotech to Design Disease-Blocking Drugs, Gains $75M

Light-Activated Therapy Improves Vision in Inherited Disease Trial

Retinal gene therapy

A clinical trial shows a light-activated protein from an injected gene improves visual abilities in people with advanced retinitis pigmentosa, an inherited eye disorder. . . . → Read More: Light-Activated Therapy Improves Vision in Inherited Disease Trial

Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Exosome illustration

Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses. . . . → Read More: Low-Dose Covid-19 Vaccine Generates Strong Immune Response

Real World Evidence Shown to Emulate Some Clinical Trials

Data pointing finger

A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials

Trial Shows Plant-Based Drug Helps Reduce Vaping

Juul e-cigarette

First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco. . . . → Read More: Trial Shows Plant-Based Drug Helps Reduce Vaping

Cancer Cell Therapy Biotech Launches, Raises $10M

Breast cancer cells, microscope image

A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M

Biotech Group Blasts Reproductive Drug Ruling

Mifeprex boxes

A biotechnology industry group calls Friday’s ruling in a Federal district court to suspend approval of the drug mifepristone “an assault on science.” . . . → Read More: Biotech Group Blasts Reproductive Drug Ruling